SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-14-023915
Filing Date
2014-04-21
Accepted
2014-04-21 17:29:51
Documents
3
Period of Report
2014-04-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K v375381_8k.htm 8-K 15388
2 EX-10.1 v375381_ex10-1.htm EX-10.1 6795
3 EX-10.2 v375381_ex10-2.htm EX-10.2 7085
  Complete submission text file 0001144204-14-023915.txt   30879
Mailing Address 155 GIBBS STREET SUITE 412 ROCKVILLE MD 20850
Business Address 155 GIBBS STREET SUITE 412 ROCKVILLE MD 20850 (734) 332-7800
Synthetic Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

IRS No.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12584 | Film No.: 14774617
SIC: 2834 Pharmaceutical Preparations